Corzide

Corzide is a brand name of bendroflumethiazide/nadolol, approved by the FDA in the following formulation(s):

CORZIDE (bendroflumethiazide; nadolol - tablet; oral)

• 
  Manufacturer: KING PHARMS
  
  Approval date: May 25, 1983
  
  Strength(s): 5MG;40MG ^[AB], 5MG;80MG ^[RLD][AB]

Has a generic version of Corzide been approved?

Yes. The following products are equivalent to Corzide:

NADOLOL AND BENDROFLUMETHAZIDE (bendroflumethiazide; nadolol tablet; oral)

• 
  Manufacturer: MYLAN
  
  Approval date: February 15, 2008
  
  Strength(s): 5MG;40MG ^[AB], 5MG;80MG ^[AB]

NADOLOL AND BENDROFLUMETHIAZIDE (bendroflumethiazide; nadolol tablet; oral)

• 
  Manufacturer: IMPAX LABS
  
  Approval date: March 30, 2007
  
  Strength(s): 5MG;40MG ^[AB], 5MG;80MG ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Corzide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Corzide.

See also...

• Corzide Consumer Information (Wolters Kluwer)
• Corzide Advanced Consumer Information (Micromedex)
• Bendroflumethiazide/Nadolol Consumer Information (Wolters Kluwer)
• Bendroflumethiazide and nadolol Consumer Information (Cerner Multum)
• Nadolol and bendroflumethiazide Advanced Consumer Information (Micromedex)